TATSUYA KAWAGUCHI

Papers (33)：

Noriyoshi Iriyama, Michihide Tokuhira, Tomoiku Takaku, Eriko Sato, Maho Ishikawa, Tomonori Nakazato, Kei-Ji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Yoshihiro Hatta, et al. Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group. LEUKEMIA RESEARCH. 2017. 54. 55-58
Koichi Miyamura, Toshihiro Miyamoto, Mitsune Tanimoto, Kazuhito Yamamoto, Shinya Kimura, Tatsuya Kawaguchi, Itaru Matsumura, Tomoko Hata, Hisashi Tsurumi, Shigeki Saito, et al. Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy. LEUKEMIA RESEARCH. 2016. 51. 11-18
Haruhiko Ninomiya, Naoshi Obara, Shigeru Chiba, Kensuke Usuki, Kaichi Nishiwaki, Itaru Matsumura, Tsutomu Shichishima, Shinichiro Okamoto, Jun-ichi Nishimura, Kazuma Ohyashiki, et al. Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2016. 104. 5. 548-558
Naoyuki Miyasaka, Osamu Miura, Tatsuya Kawaguchi, Nobuyoshi Arima, Eriko Morishita, Kensuke Usuki, Yasuyoshi Morita, Kaichi Nishiwaki, Haruhiko Ninomiya, Akihiko Gotoh, et al. Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2016. 103. 6. 703-712
Yoshitaka Kikukawa, Hiromichi Yuki, Sinya Hirata, Kazuhiko Ide, Hirotomo Nakata, Toshikazu Miyakawa, Naofumi Matsuno, Kisato Nosaka, Yuji Yonemura, Tatsuya Kawaguchi, et al. Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2015. 101. 2. 133-139

ｍore...

MISC (24)：

川口辰哉, 金倉譲, 西村純一, 二宮治彦, 橋本岳, 福山哲郎, 前田彰久, 河陽輝, 関つたえ, 村上早代子. Round Table Discussion 三位一体(医療・行政・患者)で進める難病問題 : さきがけとしてのPNH. PNH frontier : frontiers in paroxysmal nocturnal hemoglobinuria. 2016. 3. 6-17
川口辰哉, 鈴木隆浩, 中尾眞二. Round Table Discussion 各国におけるPNH治療指針の比較 : PNH診療の治療指針の最適化に向けて. PNH frontier : frontiers in paroxysmal nocturnal hemoglobinuria. 2015. 2. 7-15
川口辰哉. Monitoring of response to treatment in CML in the era of second generation tyrosine kinase inhibitors. 血液内科. 2014. 69. 2. 228-233
川口辰哉. Recent advances in the understanding and management of paroxysmal nocturnal hemoglobinuria. 血液内科. 2014. 68. 5. 624-629
二宮治彦, 川口辰哉, 西村純一. Round Table Discussion PNH診療の現状と今後の展望. PNH frontier : frontiers in paroxysmal nocturnal hemoglobinuria. 2014. 1. 7-14

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page